Unveiling MRD: Trends in Usage and Market Sentiments

As advancements in molecular and genetic technologies continue to revolutionize cancer care, MRD testing has emerged as a powerful tool for assessing treatment response, predicting disease recurrence, and guiding personalized therapeutic strategies.

For this report, we surveyed and spoke to 20 experts covering 6/10 top pharma. We also leveraged the Beacon Biomarker Database, to explore exploring the latest trends, insights, and market sentiments shaping MRD adoption and integration into clinical practice.

Do you have a future market research project that you’d like to discuss with us?